RxDoctor Payments Data

Mark Lang, MD

Family Medicine · Broadview Hts, OHNPI 1972508232

Payments from drug & device makers

$691in general payments, 2019–2025

Across 46 payments — averaging $15.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$145
  • AbbVie$136
  • Biohaven Pharmaceutical Holding Company Ltd.$61
  • AstraZeneca$54
  • Amgen$44
  • Boehringer Ingelheim$41
  • plus $208 from 11 others

What the payments were for

  • Food & beverage$691100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$691 in reported general payments places this provider in the 55th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$56,002
Medicare patients
112
Services billed
855

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin45$57,984
EliquisApixaban62$43,804
OzempicSemaglutide25$22,468
MounjaroTirzepatide19$21,837
Tresiba Flextouch U-200Insulin Degludec18$14,259
Repatha SureclickEvolocumab16$13,499
Tresiba Flextouch U-100Insulin Degludec12$4,484
SynthroidLevothyroxine Sodium35$2,959
Rosuvastatin Calcium152$1,428
Nebivolol Hcl16$993
Ezetimibe30$959
Pantoprazole Sodium63$859
Metoprolol Succinate64$835
Atorvastatin Calcium147$805
Nano 2nd Gen Pen NeedlePen Needle, Diabetic13$781

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$41$57,98445 claims
PfizerEliquis$30$43,80462 claims
Novo NordiskOzempic$13$22,46825 claims
Lilly USA, LLCMounjaro$145$21,83719 claims
AbbVieSynthroid$136$2,95935 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Broadview Hts

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →